Compositions comprising Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compositions are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.
|Original language||English (US)|
|U.S. patent number||9925180|
|State||Published - Mar 27 2018|